In sepsis, continuous and intermittent infusion of β-lactam antibiotics did not differ for mortality at 90 d

Morgan K Walker; Jeffrey R Strich

doi:10.7326/ANNALS-24-01752-JC

In sepsis, continuous and intermittent infusion of β-lactam antibiotics did not differ for mortality at 90 d

Ann Intern Med. 2024 Sep;177(9):JC102. doi: 10.7326/ANNALS-24-01752-JC. Epub 2024 Sep 3.

Authors

Morgan K Walker¹, Jeffrey R Strich¹

Affiliation

¹ National Institutes of Health, Critical Care Medicine Department, Bethesda, Maryland, USA (M.K.W., J.R.S.).

PMID: 39222506
DOI: 10.7326/ANNALS-24-01752-JC

Abstract

Dulhunty JM, Brett SJ, De Waele JJ, et al; BLING III Study Investigators. Continuous vs intermittent β-lactam antibiotic infusions in critically ill patients with sepsis: the BLING III randomized clinical trial. JAMA. 12 June 2024. [Epub ahead of print.] 38864155.

Publication types

Comment